Nicotine dependence, unspecified, with unspecified nicotine-induced disorders
ICD-10 F17.209 is a billable code used to indicate a diagnosis of nicotine dependence, unspecified, with unspecified nicotine-induced disorders.
Nicotine dependence is characterized by a strong desire to consume nicotine, leading to compulsive use despite harmful consequences. This condition often manifests as a physical and psychological addiction to nicotine, primarily found in tobacco products. Individuals may experience withdrawal symptoms such as irritability, anxiety, and cravings when attempting to quit. Unspecified nicotine-induced disorders may include a range of health issues related to nicotine use, such as respiratory problems, cardiovascular diseases, and mental health disorders. The diagnosis of nicotine dependence is crucial for guiding treatment options, which may include behavioral therapies, pharmacotherapy (such as nicotine replacement therapy), and support programs. Accurate coding is essential for effective treatment planning and insurance reimbursement, as it reflects the severity and complexity of the patient's condition.
Detailed history of substance use, including duration and frequency of nicotine use, and any previous treatment attempts.
Patients seeking help for quitting smoking, those experiencing withdrawal symptoms, or those with co-occurring mental health issues.
Consideration of the patient's overall health status and any comorbid conditions that may affect treatment.
Assessment of mental health status, including any nicotine-induced mood disorders or anxiety.
Patients with anxiety or depression who also smoke, requiring integrated treatment approaches.
Documentation should reflect the interplay between nicotine dependence and mental health conditions.
Used when a patient is counseled on quitting smoking.
Documentation of the counseling session and patient’s smoking history.
Addiction specialists may provide more intensive counseling.
F17.209 is used for nicotine dependence without withdrawal symptoms, while F17.210 is specifically for cases where withdrawal symptoms are present.
